Research | Building the Foundation for Personalized RNA Therapeutics in Heart Disease
McGill researchers have developed a new way to study why the same heart-failure treatment can help some patients recover while others continue to worsen. The research was co-led by Diego Loggia, a D2R Scholar and PhD student in McGill's Department of Pharmacology & Therapeutics.
Day in the Lab: Inspiring Girls Through Science
Last week, D2R accompanied high school girls in Grades 7-9 from Les Scientifines on a visit to the Biomedical Engineering Lab of D2R-funded researcher Caroline Wagner at McGill University. The visit offered students a firsthand look at the exciting world of science.
New approach aims to make personalized RNA therapies accessible to more children with rare genetic brain disorders
Montreal, October 23, 2026 – For families of children with rare genetic neurodevelopmental disorders, receiving a diagnosis can provide an explanation for their child’s condition, but often offers few treatment options.
Researchers at McGill University are working to change that.
The D2R Community Marks the National Day for Truth and Reconciliation
D2R community members are marking the National Day for Truth and Reconciliation by wearing custom-designed orange shirts featuring artwork by Summer (Niibin) Taylor, an Anishnawbe and Oji-Cree graphic designer.
Created as part of D2R's Research Can Be Reconciliation campaign, the artwork encourages reflection on the role research can play in advancing reconciliation through listening, learning, relationship-building, respect, and accountability.
D2R continues to invest in Canada's next generation of RNA research leaders
The 2026 D2R Scholar cohort brings D2R's investment in graduate and postdoctoral talent to more than $13.5 million, supporting 242 trainees across CanadaMontreal, September 11, 2026 – The DNA to RNA (D2R) Initiative at McGill is proud to announce the recipients of its 2026 Master's and Doctoral Scholar Awards, recognizing outstanding trainees conducting innovative research aligned with D2R's mission to advance RNA science and innovation.
New Funding Opportunity: Ethical, Legal and Social Implications (ELSI) of Genomics Catalyst Grants
Researchers at McGill University and D2R partner institutions are invited to apply for the new Ethical, Legal and Social Implications (ELSI) of Genomics Catalyst Grants, a funding opportunity designed to support research examining the socioeconomic, cultural, policy and ethical dimensions of genomic medicine.
D2R Celebrates the First Cohort of the Summer Internship Program for Black Undergraduate Students
On August 19, D2R proudly showcased the achievements of the first cohort of its Summer Internship Program for Black Undergraduate Students during a Poster Presentation event at McGill University. The event brought together interns, researchers, mentors, and community partners to celebrate 15 weeks of hands-on research and learning in the field of genomic-based RNA therapeutics.
Bringing Cancer Vaccines Closer to Patients: D2R Launches New Strategic Funding Initiative
The DNA to RNA (D2R) Initiative is launching a new Strategic Initiative on Cancer Vaccines to accelerate the development of innovative cancer vaccine therapies and bring promising discoveries closer to patients.
CTR Horizons 2026 | Registration is now open!
Registration is now officially open for CTR Horizons 2026, taking place November 25–26, 2026, at Holiday Inn & Suites Montreal Centre-ville Ouest.
New Indigenous Health Research Project Awarded to Prof Geneviève Bernard to Study a Rare Childhood Brain Disease
In the photo: Prof. Geneviève Bernard speaking at the D2R Research Symposium 2026
RiboClub 2026 to Bring International RNA Research Community to Orford, Québec
The RiboClub 2026 Annual Conference will take place October 4–8, 2026, at the Chéribourg Hotel in Orford, Québec, bringing together researchers, trainees, and industry professionals from across Canada and around the world to discuss the latest developments in RNA science.
D2R launches major international projects to advance personalized genomic medicine
Montreal, June 19, 2026 — McGill University’s DNA to RNA (D2R) initiative has announced two new international research projects aimed at accelerating personalized genomic medicine and RNA-based therapies.
EDI Internship Opportunity – Fall 2026
D2R and the Department of Equity, Ethics and Policy at McGill University launch a call for applications for an EDI Internship OpportunityOver the course of the Fall 2026 semester, work with Prof.
EDI Lunch & Learn | Accessibility in Research Labs
This event is open to everyone who wants to contribute to creating accessible research environments.
In honour of Quebec’s Week for Persons with Disabilities, D2R - in collaboration with the Quebec Interuniversity Network in Equity, Diversity and Inclusion with and the Equity Team at McGill University - invites you to a Lunch & Learn to present the new Practical Toolkit for Research Teams to foster Accessibility in Research Labs.
McGill scientists unveil “Alenomers,” a new molecular platform that could rival antibodies
Montreal, May 6, 2026 – Researchers from McGill University have introduced a groundbreaking new class of molecules that could significantly reshape drug discovery and development. The technology, called Aptamer‑Like ENcoded OligoMERs (Alenomers), combines the advantages of antibodies and DNA‑based therapeutics while overcoming key limitations of both.
